SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPoolbeg Pharma Share News (POLB)

Share Price Information for Poolbeg Pharma (POLB)

Share Price is delayed by 15 minutes
Get Live Data
7.60    -0.10 (-1.30%)
Bid:
7.50
Ask:
7.70
Spread: 0.20 (2.667%)
Market Cap: £53.59m
POLB Live PriceLast checked at - London Stock Exchange

Intraday Poolbeg Pharma Share Chart

Poolbeg Pharma News

LONDON MARKET OPEN: Stocks rise as market sentiment recovers
4 Oct 2022

LONDON MARKET OPEN: Stocks rise as market sentiment recovers

(Alliance News) - Stock prices in London opened sharply higher on Tuesday, lifted by more positive market sentiment following the UK government's tax ...

LONDON BRIEFING: Pound, oil, gold up; Truss vows fiscal responsibility
4 Oct 2022

LONDON BRIEFING: Pound, oil, gold up; Truss vows fiscal responsibility

(Alliance News) - Stocks in London are called higher on Tuesday, as the market watches closely for further clues regarding the UK's economic direction...

IN BRIEF: Poolbeg Pharma teams up for Melioidosis vaccine
27 Sep 2022

IN BRIEF: Poolbeg Pharma teams up for Melioidosis vaccine

Poolbeg Pharma PLC - London-based pharmaceutical company - On Wednesday reported it a signed an in-license agreement for the development of a Melioido...

Poolbeg inks exclusive deal for melioidosis vaccine candidate
21 Sep 2022

Poolbeg inks exclusive deal for melioidosis vaccine candidate

(Sharecast News) - Clinical-stage infectious disease pharmaceutical company Poolbeg Pharma has signed an exclusive licence agreement with University C...

IN BRIEF: Poolbeg shares rises on narrowed loss, strong pipeline
6 Sep 2022

IN BRIEF: Poolbeg shares rises on narrowed loss, strong pipeline

Poolbeg Pharma PLC - London-based pharmaceutical company - In the six months ended June 30, narrows its pretax loss to GBP1.7 million from GBP2.3 mill...

IN BRIEF: Poolbeg Pharma shares rise as first human trial begins
20 Jul 2022

IN BRIEF: Poolbeg Pharma shares rise as first human trial begins

Poolbeg Pharma PLC - London-based pharmaceutical company - Receives approval to commence its Lipopolysaccharide human clinical trial for POLB 011, a d...

Poolbeg Pharma AI model of respiratory syncytial virus starts analysis
27 Jun 2022

Poolbeg Pharma AI model of respiratory syncytial virus starts analysis

(Alliance News) - Poolbeg Pharma PLC on Monday said its build and optimisation of an artificial intelligence model of respiratory syncytial virus data...

AIM WINNERS & LOSERS: Premier Miton advances; Advance Energy retreats
27 May 2022

AIM WINNERS & LOSERS: Premier Miton advances; Advance Energy retreats

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.